Evidence map›Paper›PMID 41126424›Full record

ReviewMini reviews in medicinal chemistry2025

COPD Treatment with Beta 2-Adrenoreceptor Agonists: Medicinal Perspectives and Recent Advances.

Neha Rana, Shalini Sharma, Hridayanand Singh, Sameer Rastogi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mini reviews in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Neha RanaSchool of Pharmacy (SOP), Noida International University, Yamuna Expressway, Gautam Budh Nagar 203201, India.ORCID 0000-0002-8390-9898
Shalini SharmaSchool of Pharmacy (SOP), Noida International University, Yamuna Expressway, Gautam Budh Nagar 203201, India.
Hridayanand SinghGalgotias College of Pharmacy, Knowledge Park -II, Greater Noida, 201310, Uttar Pradesh, India.ORCID 0000-0001-6866-0476
Sameer RastogiSchool of Pharmacy (SOP), Noida International University, Yamuna Expressway, Gautam Budh Nagar 203201, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition defined by persistent bronchitis, emphysema, and structural remodelling. The number of cases has risen globally; however, limited viable remedies exist. It is linked to airway blockage, oxidative stress, chronic conditions, inflammation, excessive mucus production, and increased autophagy and cellular senescence. Beta-2 adrenergic receptors (β

Indexed as

Adrenergic beta-2 Receptor AgonistsBronchodilator AgentsPulmonary Disease, Chronic ObstructiveReceptors, Adrenergic, beta-2HumansAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsReceptors, Adrenergic, beta-2Beta-2 adrenergic receptorsbronchodilatorsCOPDnatural βnovel βstructure-activity relationship investigations

Identifiers

PMID41126424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.